小鼠IgA调节人类肠道微生物群,有炎症性肠道疾病的患者
Keishu Takahashi1,2, Naoki Morita1, Ryutaro Tamano1
1Institute for Quantitative Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan, Laboratory of Immunology and Infection Control.
Journal of gastroenterology
|June 14, 2024
概括
小鼠免疫球蛋白A (IgA) 在炎症性肠病 (IBD) 患者的肠道失调治疗中显示出潜在的潜力. 这种疗法调节肠道微生物群,为IBD管理提供了一种新方法.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物不平衡,肠道微生物不平衡,在炎症性肠病 (IBD) 患者中观察到.
- 分泌的免疫球蛋白A (IgA) 调节肠道微生物群,但其在IBD相关失生症中的作用尚不清楚.
- 治疗IBD失生症的有效干预措施仍然有限.
研究的目的:
- 为了研究人类内源性IgA与IBD患者肠道细菌的结合活性.
- 为了确定小鼠单克隆IgA是否可以调节IBD患者的人类肠道微生物群.
- 评估小鼠IgA在治疗IBD肠道失调症中的治疗潜力.
主要方法:
- 使用MACS和细胞分类器对IgA结合和未结合的细菌进行分类.
- 通过16S rRNA测序分析细菌组成,以确定IgA标.
- 将老鼠IgA给殖民于IBD患者微生物群的gnotobiotic小鼠,以评估其影响.
主要成果:
- 在IBD患者中,人类内源性IgA对肠道细菌表现出异常的结合.
- 鼠标IgA被证明与人类微生物群结合,包括大肠杆菌,并对rW27.27观察到特定的抑制活性.
- 通过口服小鼠IgA给药降低了便中的利波卡林2 (一种炎症生物标志物),并改善了IBD微生物群的小鼠的肠道失调.
结论:
- 鼠标IgA有效地与人类肠道微生物群结合并调节,向结肠病原菌.
- 通过口服小鼠IgA,通过纠正肠道失调,为IBD提供了可行的治疗策略.
更多相关视频
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Irritable Bowel Syndrome I: Introduction
268
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
268
Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
What is Monogastric Digestion?
71.1K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.1K
Inflammatory Bowel Disease I: Ulcerative Colitis
161
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
161


